KEGG   DRUG: Pemivibart
Entry
D12876                      Drug                                   
Name
Pemivibart (INN);
Pemgarda (TN)
Product
  Other
Sequence
(Heavy chain)
EVQLVESGGG LVKPGGSLRL SCAASGFTFG SYEMNWVRQA PGKGLEWVSS ISEDGYSTYY
PDSLKGRFTI SRDSAKNSLY LQMNSLRADD TAVYYCARDF GGDTAWAGTG FTYWGQGTLV
TVSSASTKGP SVFPLAPSSK STSGGTAALG CLVKDYFPEP VTVSWNSGAL TSGVHTFPAV
LQSSGLYSLS SVVTVPSSSL GTQTYICNVN HKPSNTKVDK RVEPKSCDKT HTCPPCPAPE
LLGGPSVFLF PPKPKDTLMI SRTPEVTCVV VDVSHEDPEV KFNWYVDGVE VHNAKTKPRE
EQYNSTYRVV SVLTVLHQDW LNGKEYKCKV SNKALPAPIE KTISKAKGQP REPQVYTLPP
SREEMTKNQV SLTCLVKGFY PSDIAVEWES NGQPENNYKT TPPVLDSDGS FFLYSKLTVD
KSRWQQGNVF SCSVLHEALH AHYTQKSLSL SPGK
(Light chain)
QSVLTQPPSV SGAPGQRITI SCTGSSSNIG AGYDVHWYQQ LPGTAPKLLI YGSSSRNSGV
PDRFSGSKSG TSASLAITGL QAEDEADYYC QSYDSSLSVL YTFGTGTKVT VLGQPKAAPS
VTLFPPSSEE LQANKATLVC LISDFYPGAV TVAWKADSSP VKAGVETTTP SKQSNNKYAA
SSYLSLTPEQ WKSHRSYSCQ VTHEGSTVEK TVAPTECS
(Disulfide bridge: H22-H96, H151-H207, H227-L217, H233-H'233, H236-H'236, H268-H328, H374-H432, H'22-H'96, H'151-H'207, H'227-L'217, H'268-H'328, H'374-H'432, L22-L90, L140-L199, L'22-L'90, L'140-L'199)
  Type
Peptide
Class
Antiviral
 DG03174  Anti-SARS-CoV-2 agent
Remark
Product: D12876<US>
Efficacy
Antiviral
  Disease
Coronavirus disease 2019 [DS:H02398]
  Type
Monoclonal antibody
Target
SARS-CoV-2 spike glycoprotein S1 [KO:K25001]
  Pathway
ko03230  Viral genome structure
ko03262  Virion - Coronavirus
Brite
Drug groups [BR:br08330]
 Antiviral
  DG03174  Anti-SARS-CoV-2 agent
   D12876  Pemivibart
Antimicrobials [BR:br08307]
 Antivirals
  Entry, fusion or uncoating inhibitor
   Coronavirus spike protein
    D12876  Pemivibart (INN) <US>
Other DBs
CAS: 2858673-18-2
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system